Sin conexión a internet: se muestra la versión guardada de la página.

Quest Diagnostics…

USUSD
← Al screener

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
questdiagnostics.com
Relaciones con los inversores
ir.questdiagnostics.com/overview/default.aspx
Sector
Health Care · Medical Specialities
Sede central
Madison, United States
Consejero delegado
Steve Rusckowski
Empleados
46 000
Fundada
1967
Cotiza desde
29.01.2018 (LSE:0KSX)
Acciones en circulación
110.37 M a 2026-07-15
Capital flotante
109.81 M
Capitalización bursátil
25.21 mil M USD
Insiders
0.43%
Inversores institucionales
98.9%
Industria (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Ratio de reparto
34.2%
FCF
1.35 mil M USD
27%
Deuda
5.64 mil M USD
3.7 a. de FCF
Racha de dividendos
22 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksDGX principalUSD230.81 +1.65%acciones ordinarias
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%acciones ordinarias

Precio en 3 meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Per year, US:DGX: 3.38 USD (4 pagos)

Quest Diagnostics Incorporated (DGX) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 3.38 USD por acción (pagos: 4). Eso representa aproximadamente el 1.46% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 05.01.2027. Historial de dividendos ininterrumpido: 22 años.

Fecha exPagoImporte%TipoTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %trimestralUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.4 %trimestralUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %trimestralUS:DGX
2026-01-132026-01-280.8000 USD0.3/1.4 %trimestralUS:DGX
2025-10-032025-10-200.8000 USD0.3/1.4 %trimestralUS:DGX
2025-07-072025-07-210.8000 USD0.3/1.3 %trimestralUS:DGX
2025-04-072025-04-210.8000 USD0.3/1.3 %trimestralUS:DGX
2025-01-142025-01-290.7500 USD0.3/≈1.3 %trimestralUS:DGX
2024-10-042024-10-210.7500 USD0.3/≈1.3 %trimestralUS:DGX
2024-07-082024-07-220.7500 USD0.3/≈1.3 %trimestralUS:DGX
anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
Blackrock Inc.8.4%9.28 M2026-06-30
Vanguard Capital Managem…6.55%7.23 M2026-06-30
Vanguard Portfolio Manag…5.55%6.13 M2026-06-30
State Street Corporation5%5.52 M2026-06-30
Price (T.Rowe) Associate…4.93%5.44 M2026-06-30
Boston Partners4.3%4.74 M2026-06-30
JPMORGAN CHASE & CO3.19%3.52 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 M2026-06-30
Geode Capital Management…2.84%3.14 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 M2026-06-30
Morgan Stanley2.23%2.46 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 M2026-06-30
Edgepoint Investment Gro…2.04%2.25 M2026-06-30
iShares Trust-iShares Co…1.33%1.47 M2026-08-31
Fidelity Concord Street…1.3%1.43 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 M2026-08-31
John Hancock Funds III-D…1.09%1.2 M2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 M2026-06-30
T. Rowe Price Dividend G…1%1.11 M2026-06-30
John Hancock Funds III-D…0.96%1.06 M2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22